Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parametric Survival Analysis: Weibull and Exponential Methods01:14

Parametric Survival Analysis: Weibull and Exponential Methods

Parametric survival analysis models survival data by assuming a specific probability distribution for the time until an event occurs. The Weibull and exponential distributions are two of the most commonly used methods in this context, due to their versatility and relatively straightforward application.
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
Introduction To Survival Analysis01:18

Introduction To Survival Analysis

Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time until a...
Survival Tree01:19

Survival Tree

Survival trees are a non-parametric method used in survival analysis to model the relationship between a set of covariates and the time until an event of interest occurs, often referred to as the "time-to-event" or "survival time." This method is particularly useful when dealing with censored data, where the event has not occurred for some individuals by the end of the study period, or when the exact time of the event is unknown.
 Building a Survival Tree
Constructing a survival tree begins...
Truncation in Survival Analysis01:09

Truncation in Survival Analysis

Truncation in survival analysis refers to the exclusion of individuals or events from the dataset based on specific criteria related to the time of the event. This exclusion can happen in two primary forms: left truncation and right truncation.
Left truncation occurs when individuals who experienced the event of interest before a certain time are not included in the study. This is often due to a "delayed entry" into the study where only those who survive until a certain entry point are observed.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rank-based learning: a novel high-throughput algorithm resilient to missing data and effective for datasets with small sample size.

Briefings in bioinformatics·2026
Same author

Digital twins in healthcare: a comprehensive review and future directions.

Frontiers in digital health·2025
Same author

SMAGS-LASSO: A Novel Feature Selection Method for Sensitivity Maximization in Early Cancer Detection.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2025
Same author

AUPRC: a metric for evaluating the performance of in-silico perturbation methods in identifying differentially expressed genes.

Briefings in bioinformatics·2025
Same author

Oral microbial signatures of head and neck cancer patients with diverse longitudinal oral mucositis severity patterns.

bioRxiv : the preprint server for biology·2025
Same author

CAT: a conditional association test for microbiome data using a permutation approach.

Briefings in bioinformatics·2025

Related Experiment Video

Updated: Jun 22, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

A Bayesian semiparametric survival model with longitudinal markers.

Song Zhang1, Peter Müller, Kim-Anh Do

  • 1Department of Clinical Sciences, Division of Biostatistics, University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA. Song.Zhang@utsouthwestern.edu

Biometrics
|June 11, 2009
PubMed
Summary

This study presents a new statistical model for analyzing clinical trial data in metastatic prostate cancer patients. The model improves predictions of time to progression by jointly analyzing longitudinal markers and event times, accounting for patient heterogeneity and potential cures.

More Related Videos

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

Related Experiment Videos

Last Updated: Jun 22, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

Area of Science:

  • Biostatistics
  • Clinical Trials
  • Cancer Research

Background:

  • Clinical trials for metastatic prostate cancer often involve patients with varied treatment histories, leading to heterogeneous populations.
  • Predicting time to progression in such diverse groups is statistically challenging, especially when incorporating longitudinal markers as covariates.

Purpose of the Study:

  • To develop a robust semiparametric model for joint inference of longitudinal data and event times in cancer clinical trials.
  • To address challenges in statistical inference arising from patient heterogeneity and the inclusion of longitudinal markers.

Main Methods:

  • A semiparametric joint model was developed for longitudinal data and event time, incorporating a nonparametric Pólya tree prior for the event time distribution.
  • A mixed-effects model was assumed for the longitudinal data.
  • The model addresses the challenge of covariate regression in nonparametric event time models by factoring the joint distribution and modeling the reverse conditional distribution.

Main Results:

  • The proposed model allows for joint inference of longitudinal markers and time to progression.
  • It accommodates the possibility of cure for some patients.
  • The method effectively incorporates regression on covariates within a nonparametric event time framework.

Conclusions:

  • The developed semiparametric model offers a flexible and powerful approach for analyzing complex clinical trial data in metastatic prostate cancer.
  • This method enhances the ability to predict treatment outcomes by jointly modeling key patient data.
  • The approach provides a valuable tool for statistical inference in heterogeneous patient populations.